EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Nanoliposomal curcumin as a potential pro-apoptotic agent for cervical cancer: Evidence from Bcl-2 and Bax modulation in HeLa cells

Subandi Subandi, Oktalia N Aisyah, Bayu Lestari

Narra J · 07.07.2026 · 6 (2) · e3126

DOI: 10.52225/narra.v6i2.3126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Narra J, online erschienen am 07.07.2026. Verfasst von Subandi Subandi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Midwifery, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia. Hauptthemen laut MEDLINE: Curcumin, bcl-2-Associated X Protein, Uterine Cervical Neoplasms, Proto-Oncogene Proteins c-bcl-2. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer remains a major cause of cancer-related mortality, and treatment effectiveness is often limited by drug resistance and systemic toxicity. Curcumin has shown anticancer activity, but its clinical translation is constrained by poor solubility and low bioavailability. Nanoliposomal curcumin (Cur-NLPs) may improve intracellular delivery; however, its dose-dependent effect on apoptosis-related proteins in cervical cancer cells remains insufficiently defined. This study evaluated the dose-dependent modulation of Bcl-2 and Bax protein expression by Cur-NLPs in HeLa cells. HeLa cells were assigned to five groups: negative control, cisplatin 5 µg/mL as positive control, and Cur-NLPs at 100, 150, and 200 µg/mL. After 24 hours of treatment, Bcl-2 and Bax expression were assessed by immunofluorescence and quantified as corrected total cell fluorescence (CTCF). Data were analyzed using one-way ANOVA, Tukey HSD post hoc test, Pearson correlation, and linear regression. Significant between-group differences were observed for both Bcl-2 (F=8.99; p=0.002) and Bax (F=132.38; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Curcuminbcl-2-Associated X ProteinUterine Cervical NeoplasmsProto-Oncogene Proteins c-bcl-2ApoptosisAntineoplastic AgentsHumansFemaleHeLa CellsLiposomesNanoparticles

Stichwörter der Autor:innen

BaxBcl-2Cervical cancerapoptosisnanoliposomal curcumin

Substanzen

Curcuminbcl-2-Associated X ProteinProto-Oncogene Proteins c-bcl-2LiposomesAntineoplastic AgentsBAX protein, humanBCL2 protein, human

Autor:innen und Institutionen

  • Department of Midwifery, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
  • Master Program in Midwifery, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
  • Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.

Zitieren

APA

Subandi, S., Aisyah, O. N., & Lestari, B. (2026). Nanoliposomal curcumin as a potential pro-apoptotic agent for cervical cancer: Evidence from Bcl-2 and Bax modulation in HeLa cells. Narra J, 6(2), e3126. https://doi.org/10.52225/narra.v6i2.3126

Vancouver

Subandi S, Aisyah ON, Lestari B. Nanoliposomal curcumin as a potential pro-apoptotic agent for cervical cancer: Evidence from Bcl-2 and Bax modulation in HeLa cells. Narra J. 2026;6(2):e3126. doi:10.52225/narra.v6i2.3126

BibTeX
@article{Subandi2026,
  author = {Subandi, Subandi and Aisyah, Oktalia N and Lestari, Bayu},
  title = {Nanoliposomal curcumin as a potential pro-apoptotic agent for cervical cancer: Evidence from Bcl-2 and Bax modulation in HeLa cells},
  journal = {Narra J},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {e3126},
  doi = {10.52225/narra.v6i2.3126}
}
Kostenlos starten →